Important considerations in the management of Graves’ disease in pregnant women

References

• Weetman AP. Graves’ disease. N Engl J Med 2000;343:1236-48
   PubMed Web of Science ®Google Scholar
• Carlé A, Pedersen IB, Knudsen N, et al. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol 2011;164:801-9
   PubMed Web of Science ®Google Scholar
• Okosieme OE, Marx H, Lazarus JH. Medical management of thyroid dysfunction in pregnancy and the postpartum. Expert Opin Pharmacother 2008;9:2281-93
   PubMed Web of Science ®Google Scholar
• McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 1992;2:155-9
   PubMed Web of Science ®Google Scholar
• Cooper DS. Antithyroid drugs. N Engl J Med 2005;352:905-17
   PubMed Web of Science ®Google Scholar
• Brent GA. Clinical practice. Graves’ disease. N Engl J Med 2008;358:2594-605
   PubMed Web of Science ®Google Scholar
• Biondi B. How could we improve the increased cardiovascular mortality in patients with overt and subclinical hyperthyroidism? Eur J Endocrinol 2012;167:295-9
   Google Scholar
• Brandt F, Green A, Hegedüs L, et al. A critical review and meta-analysis of the association between overt hyperthyroidism and mortality. Eur J Endocrinol 2011;165:491-7
   PubMed Web of Science ®Google Scholar
• Bartalena L, Tanda ML. Clinical practice. Graves’ ophthalmopathy. N Engl J Med 2009;360:994-1001
   PubMed Web of Science ®Google Scholar
• Wiersinga WM. Quality of life in Graves’ ophthalmopathy. Best Pract Res Clin Endocrinol Metab 2012;26:359-70
   PubMed Web of Science ®Google Scholar
• Coulter I, Frewin S, Krassas GE, et al. Psychological implications of Graves’ orbitopathy. Eur J Endocrinol 2007;157:127-31
   PubMed Web of Science ®Google Scholar
• Estcourt S, Vaidya B, Quinn A, et al. The impact of thyroid eye disease upon patients’ wellbeing: a qualitative analysis. Clin Endocrinol (Oxf) 2008;68:635-9
   Google Scholar
• Krassas GE, Poppe K, Glinoer D. Thyroid Function and Human Reproductive Health. Endocr Rev 2010;31:702-55
   PubMed Web of Science ®Google Scholar
• Lazarus JH. Thyroid function in pregnancy. Br Med Bull 2011;97:137-48
   PubMed Web of Science ®Google Scholar
• Andersen SL, Olsen J, Carle A, et al. Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish population-based study. J Clin Endocrinol Metab 2015;100:1164-71
   PubMed Web of Science ®Google Scholar
• Millar LK, Wing DA, Leung AS, et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994;84:946-9
   PubMed Web of Science ®Google Scholar
• Davis LE, Lucas MJ, Hankins GD, et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989;160:63-70
   PubMed Web of Science ®Google Scholar
• Lo JC, Rivkees S, Chandra M, et al. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system. Thyroid 2015. [Epub ahead of print]
   Google Scholar
• Leon G, Murcia M, Rebagliato M, et al. Maternal thyroid dysfunction during gestation, preterm delivery, and birthweight. the infancia y medio ambiente cohort, Spain. Paediatr Perinat Epidemiol 2015;29:113-22
   PubMed Web of Science ®Google Scholar
• Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, et al. Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxf) 2001;54:365-70
   PubMed Web of Science ®Google Scholar
• Andersen SL, Olsen J, Wu CS, et al. Spontaneous abortion, stillbirth and hyperthyroidism: a Danish population-based study. Eur Thyroid J 2014;3:164-72
   PubMedGoogle Scholar
• Medici M, Korevaar TI, Schalekamp-Timmermans S, et al. Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the generation R study. J Clin Endocrinol Metab 2014;99:E2591-8
   PubMed Web of Science ®Google Scholar
• Easterling TR, Schmucker BC, Carlson KL, et al. Maternal hemodynamics in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1991;78:348-52
   PubMedGoogle Scholar
• Andersen SL, Laurberg P, Wu CS, et al. Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study. BJOG 2014;121:1365-74
   PubMed Web of Science ®Google Scholar
• Andersen SL, Laurberg P, Wu CS, et al. Maternal thyroid dysfunction and risk of seizure in the child: a Danish nationwide cohort study. J Pregnancy 2013;2013:636705
   Google Scholar
• Zakarija M, McKenzie JM. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves’ disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 1983;57:1036-40
   PubMed Web of Science ®Google Scholar
• Evans C, Gregory JW, Barton J, et al. Transient congenital hypothyroidism due to thyroid-stimulating hormone receptor blocking antibodies: a case series. Ann Clin Biochem 2011;48:386-90
   PubMed Web of Science ®Google Scholar
• Laurberg P, Bournaud C, Karmisholt J, et al. Management of Graves’ hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009;160:1-8
   PubMed Web of Science ®Google Scholar
• Mestman JH. Hyperthyroidism in pregnancy. Curr Opin Endocrinol Diabetes Obes 2012;19:394-401
   PubMed Web of Science ®Google Scholar
• Polak M, Le Gac I, Vuillard E, et al. Fetal and neonatal thyroid function in relation to maternal Graves’ disease. Best Pract Res Clin Endocrinol Metab 2004;18:289-302
   PubMed Web of Science ®Google Scholar
• Momotani N, Noh J, Oyanagi H, et al. Antithyroid drug therapy for Graves’ disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med 1986;315:24-8
   PubMed Web of Science ®Google Scholar
• Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves’ hyperthyroidism. J Clin Endocrinol Metab 1997;82:3633-6
   PubMed Web of Science ®Google Scholar
• Lee YS, Loke KY, Ng SC, et al. Maternal thyrotoxicosis causing central hypothyroidism in infants. J Paediatr Child Health 2002;38:206-8
   PubMed Web of Science ®Google Scholar
• Casey BM, Dashe JS, Wells CE, et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006;107:337-41
   PubMed Web of Science ®Google Scholar
• Medici M, Timmermans S, Visser W, et al. Maternal thyroid hormone parameters during early pregnancy and birth weight: the Generation R Study. J Clin Endocrinol Metab 2013;98:59-66
   PubMed Web of Science ®Google Scholar
• Tamaki H, Itoh E, Kaneda T, et al. Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves’ disease. Thyroid 1993;3:189-93
   Google Scholar
• Davies TF. The thyroid immunology of the postpartum period. Thyroid 1999;9:675-84
   PubMed Web of Science ®Google Scholar
• Elenkov IJ, Wilder RL, Bakalov VK, et al. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001;86:4933-8
   PubMed Web of Science ®Google Scholar
• Glinoer D. Thyroid hyperfunction during pregnancy. Thyroid 1998;8:859-64
   PubMed Web of Science ®Google Scholar
• Tsuruta E, Tada H, Tamaki H, et al. Pathogenic role of asialo human chorionic gonadotropin in gestational thyrotoxicosis. J Clin Endocrinol Metab 1995;80:350-5
   PubMed Web of Science ®Google Scholar
• Rodien P, Bremont C, Sanson ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998;339:1823-6
   PubMed Web of Science ®Google Scholar
• Nakamura H, Miyauchi A, Miyawaki N, et al. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab 2013;98:4776-83
   PubMed Web of Science ®Google Scholar
• Tajiri J, Noguchi S, Murakami T, et al. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med 1990;150:621-4
   PubMed Web of Science ®Google Scholar
• Cooper DS, Rivkees SA. Putting propylthiouracil in perspective. J Clin Endocrinol Metab 2009;94:1881-2
   PubMed Web of Science ®Google Scholar
• Mortimer RH, Cannell GR, Addison RS, et al. Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997;82:3099-102
   PubMed Web of Science ®Google Scholar
• Taylor PN, Vaidya B. Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy. Eur Thyroid J 2012;1:176-85
   PubMedGoogle Scholar
• Karlsson FA, Axelsson O, Melhus H. Severe embryopathy and exposure to methimazole in early pregnancy. J Clin Endocrinol Metab 2002;87:947-9
   PubMed Web of Science ®Google Scholar
• Johnsson E, Larsson G, Ljunggren M. Severe malformations in infant born to hyperthyroid woman on methimazole. Lancet 1997;350:1520
   PubMed Web of Science ®Google Scholar
• Bowman P, Osborne NJ, Sturley R, et al. Carbimazole embryopathy: implications for the choice of antithyroid drugs in pregnancy. QJM 2012;105:189-93
   PubMed Web of Science ®Google Scholar
• Bowman P, Vaidya B. Suspected Spontaneous Reports of Birth Defects in the UK Associated with the Use of Carbimazole and Propylthiouracil in Pregnancy. J Thyroid Res 2011;2011:235130
   PubMedGoogle Scholar
• Clementi M, Di Gianantonio E, Pelo E, et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999;83:43-6
   PubMed Web of Science ®Google Scholar
• Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol (Oxf) 1984;20:695-700
   PubMed Web of Science ®Google Scholar
• Di Gianantonio E, Schaefer C, Mastroiacovo PP, et al. Adverse effects of prenatal methimazole exposure. Teratology 2001;64:262-6
   PubMedGoogle Scholar
• Barbero P, Valdez R, Rodriguez H, et al. Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study. Am J Med Genet A 2008;146A:2390-5
   PubMed Web of Science ®Google Scholar
• Yoshihara A, Noh J, Yamaguchi T, et al. Treatment of graves’ disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 2012;97:2396-403
   PubMed Web of Science ®Google Scholar
• Clementi M, Di Gianantonio E, Cassina M, et al. Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab 2010;95:E337-41
   PubMed Web of Science ®Google Scholar
• Chen CH, Xirasagar S, Lin CC, et al. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG 2011;118:1365-73
   PubMed Web of Science ®Google Scholar
• Korelitz JJ, McNally DL, Masters MN, et al. Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States. Thyroid 2013;23:758-65
   PubMed Web of Science ®Google Scholar
• Andersen SL, Olsen J, Wu CS, et al. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab 2013;98:4373-81
   PubMed Web of Science ®Google Scholar
• Andersen SL, Olsen J, Wu CS, et al. Severity of birth defects after propylthiouracil exposure in early pregnancy. Thyroid 2014;24:1533-40
   PubMed Web of Science ®Google Scholar
• Laurberg P, Andersen SL. Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk? Eur J Endocrinol 2014;171:R13-20
   PubMed Web of Science ®Google Scholar
• Lazarus JH. Pre-conception counselling in graves’ disease. Eur Thyroid J 2012;1:24-9
   PubMedGoogle Scholar
• Rotondi M, Cappelli C, Pirali B, et al. The effect of pregnancy on subsequent relapse from Graves’ disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab 2008;93:3985-8
   PubMed Web of Science ®Google Scholar
• Yoshihara A, Noh JY, Watanabe N, et al. Lower incidence of postpartum thyrotoxicosis in women with Graves disease treated by radioiodine therapy than by subtotal thyroidectomy or with antithyroid drugs. Clin Nucl Med 2014;39:326-9
   PubMed Web of Science ®Google Scholar
• Laurberg P, Wallin G, Tallstedt L, et al. TSH-receptor autoimmunity in Graves’ disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. Eur J Endocrinol 2008;158:69-75
   PubMed Web of Science ®Google Scholar
• De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012;97:2543-65
   PubMed Web of Science ®Google Scholar
• Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011;21:1081-125
   PubMed Web of Science ®Google Scholar
• Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011;21:593-646
   PubMed Web of Science ®Google Scholar
• Atkinson S, McGregor AM, Kendall-Taylor P, et al. Effect of radioiodine on stimulatory activity of Graves’ immunoglobulins. Clin Endocrinol (Oxf) 1982;16:537-43
   Google Scholar
• Abeillon-du Payrat J, Chikh K, Bossard N, et al. Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Eur J Endocrinol 2014;171:451-60
   PubMed Web of Science ®Google Scholar
• Laurberg P, Nygaard B, Glinoer D, et al. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998;139:584-6
   PubMed Web of Science ®Google Scholar
• Johansen K, Andersen AN, Kampmann JP, et al. Excretion of methimazole in human milk. Eur J Clin Pharmacol 1982;23:339-41
   PubMed Web of Science ®Google Scholar
• Azizi F, Amouzegar A. Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol 2011;164:871-6
   PubMed Web of Science ®Google Scholar
• British Thyroid Association and the Association for Clinical Biochemistry. UK Guidelines for the use of thyroid function tests. 2006. Available from: www.british-thyroid-association.org/Guidelines/
   Google Scholar
• Bahn RS, Burch HS, Cooper DS, et al. The Role of Propylthiouracil in the Management of Graves’ Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration. Thyroid 2009;19:673-4
   PubMedGoogle Scholar
• Rivkees SA. 63 years and 715 days to the ‘boxed warning’: unmasking of the propylthiouracil problem. Int J Pediatr Endocrinol 2010;2010:658267
   PubMedGoogle Scholar
• Napier C, Pearce SH. Rethinking antithyroid drugs in pregnancy. Clin Endocrinol (Oxf) 2015;82:475-7
   Google Scholar
• Khan I, Witczak JK, Hadjieconomou S, et al. Preconception thyroid-stimulating hormone and pregnancy outcomes in women with hypothyroidism. Endocr Pract 2013;19:656-62
   PubMed Web of Science ®Google Scholar
• Taylor PN, Minassian C, Rehman A, et al. TSH levels and risk of miscarriage in women on long-term levothyroxine: a community-based study. J Clin Endocrinol Metab 2014;99:3895-902
   PubMed Web of Science ®Google Scholar
• Watt T, Cramon P, Bjorner JB, et al. Selenium supplementation for patients with Graves’ hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial. Trials 2013;14:119
   PubMed Web of Science ®Google Scholar
• Marcocci C, Kahaly GJ, Krassas GE, et al. Selenium and the course of mild Graves’ orbitopathy. N Engl J Med 2011;364:1920-31
   PubMed Web of Science ®Google Scholar
• Salvi M, Vannucchi G, Beck-Peccoz P. Potential utility of rituximab for Graves’ orbitopathy. J Clin Endocrinol Metab 2013;98:4291-9
   PubMed Web of Science ®Google Scholar